FIELDS HEIDI has filed 10 insider transactions across 2 companies since March 2023.
Most recent transaction: a grant/award of 10500 shares of Phathom Pharmaceuticals, Inc. ($PHAT) on June 03, 2025.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 3, 2025 | Phathom Pharmaceuticals, Inc. | $PHAT | FIELDS HEIDI | Not found | A | Common Stock | 10500 | $0.00 | 30,000.0000 | 63,176,210 | 53.85% | 0.02% |
| June 3, 2025 | Phathom Pharmaceuticals, Inc. | $PHAT | FIELDS HEIDI | Not found | A | Stock Option (Right to Buy) | 17500 | $0.00 | 17,500.0000 | 63,176,210 | 9999.99% | 0.03% |
| March 14, 2025 | AGILENT TECHNOLOGIES, INC. | $A | FIELDS HEIDI | Director | A | Common Stock | 1819 | $121.18 | 58,851.2520 | 291,000,000 | 3.19% | 0.00% |
| May 23, 2024 | Phathom Pharmaceuticals, Inc. | $PHAT | FIELDS HEIDI | Not found | A | Common Stock | 10500 | $0.00 | 19,500.0000 | 51,289,092 | 116.67% | 0.02% |
| May 23, 2024 | Phathom Pharmaceuticals, Inc. | $PHAT | FIELDS HEIDI | Not found | A | Stock Option (Right to Buy) | 17500 | $0.00 | 17,500.0000 | 51,289,092 | 50.00% | 0.03% |
| March 15, 2024 | AGILENT TECHNOLOGIES, INC. | $A | FIELDS HEIDI | Director | A | Common Stock | 1678 | $147.48 | 56,653.6640 | 296,000,000 | 3.05% | 0.00% |
| March 5, 2024 | AGILENT TECHNOLOGIES, INC. | $A | FIELDS HEIDI | Director | S | Common Stock | 1658 | $144.34 | 54,975.6640 | 296,000,000 | 2.93% | 0.00% |
| May 25, 2023 | Phathom Pharmaceuticals, Inc. | $PHAT | FIELDS HEIDI | Director | A | Stock Option (Right to Buy) | 15000 | $0.00 | 15,000.0000 | 0 | 9999.99% | 0.00% |
| May 25, 2023 | Phathom Pharmaceuticals, Inc. | $PHAT | FIELDS HEIDI | Director | A | Common Stock | 9000 | $0.00 | 9,000.0000 | 0 | 9999.99% | 0.00% |
| March 16, 2023 | AGILENT TECHNOLOGIES, INC. | $A | FIELDS HEIDI | Director | A | Common Stock | 1658 | $136.82 | 56,221.5920 | 0 | 3.04% | 0.00% |